Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.

@article{Raghu2008TreatmentOI,
  title={Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.},
  author={Ganesh Raghu and Kevin K. Brown and Ulrich Costabel and Vincent Cottin and Roland M du Bois and Joseph A. Lasky and Michiel Thomeer and James P. Utz and Rezaul K Khandker and Lawrence McDermott and Saeed Fatenejad},
  journal={American journal of respiratory and critical care medicine},
  year={2008},
  volume={178 9},
  pages={948-55}
}
RATIONALE An efficacious medical therapy for idiopathic pulmonary fibrosis (IPF) remains elusive. OBJECTIVES To explore the efficacy and safety of etanercept in the treatment of IPF. METHODS This was a randomized, prospective, double-blind, placebo-controlled, multicenter exploratory trial in subjects with clinically progressive IPF. Primary endpoints included changes in the percentage of predicted FVC and lung diffusing capacity for carbon monoxide corrected for hemoglobin (Dl(CO(Hb))) and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 104 extracted citations

Similar Papers

Loading similar papers…